Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial

COPD
Vincent S FanNett Research Group

Abstract

This study reports the costs associated with rehabilitation among participants in the National Emphysema Treatment Trial (NETT), and evaluates factors associated with adherence to rehabilitation. Pulmonary rehabilitation is recommended for moderate-to-severe COPD and required by the Centers for Medicare and Medicaid Services (CMS) prior to lung volume reduction surgery (LVRS). Between January 1998 and July 2002, 1,218 subjects with emphysema and severe airflow limitation (FEV(1) < or = 45% predicted) were randomized. Primary outcome measures were designated as mortality and maximal exercise capacity 2 years after randomization. Pre-randomization, estimated mean total cost per patient of rehabilitation was $2,218 (SD $314; 2006 dollars) for the medical group and $2,187 (SD $304) for the surgical group. Post-randomization, mean cost per patient in the medical and surgical groups was $766 and $962 respectively. Among patients who attended > or = 1 post-randomization rehabilitation session, LVRS patients, patients with an FEV(1) > or = 20% predicted, and higher education were significantly more likely to complete rehabilitation. Patients with depressive and anxiety symptoms, and those who live > 36 miles compared to < 6 miles away ...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Aug 1, 1997·Chest·R S GoldsteinD Feeny
Nov 1, 1995·Medical Care Research and Review : MCRR·C S Phibbs, H S Luft
Oct 13, 2001·The New England Journal of Medicine·UNKNOWN National Emphysema Treatment Trial Research GroupRobert Wise
Feb 26, 2003·Revue des maladies respiratoires·A CuvelierF Chabot
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
Mar 5, 2004·The New England Journal of Medicine·Bartolome R CelliHoward J Cabral
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Tanisha CarinoSean Tunis
Dec 16, 2005·Chest·Andrew L RiesUNKNOWN National Emphysema Treatment Trial Research Group
Mar 18, 2006·American Journal of Respiratory and Critical Care Medicine·Fernando J MartinezUNKNOWN NETT Research Group
May 2, 2006·Thorax·Y LacasseF Maltais

❮ Previous
Next ❯

Citations

Jan 25, 2012·Journal of Palliative Medicine·Arif H KamalAmy P Abernethy
Jul 16, 2011·American Journal of Respiratory and Critical Care Medicine·Gerard J CrinerFernando J Martinez
Dec 31, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Suzanne C Lareau, Barbara P Yawn
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Martijn A SpruitUNKNOWN ATS/ERS Task Force on Pulmonary Rehabilitation
Mar 27, 2009·The New England Journal of Medicine·Richard Casaburi, Richard ZuWallack
May 31, 2014·Clinics in Chest Medicine·Vincent S Fan, Paula M Meek
Mar 1, 2013·The Physician and Sportsmedicine·Jessica Favero ButtsKevin B Gebke
Oct 2, 2015·Scandinavian Journal of Caring Sciences·Helle MatharNiels Sandholm Larsen
Mar 31, 2015·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Leonard ChowNicola A Hanania
Dec 27, 2011·Respiratory Medicine·S L HarrisonS J Singh
Jun 2, 2009·Respiratory Medicine·Maarten J FischerAdrian A Kaptein
May 14, 2014·Respiratory Medicine·Andrew M BuschMichael P Carey
Jun 19, 2016·Chronic Respiratory Disease·Nola CecinsSue Jenkins
Aug 3, 2016·Archivos de bronconeumología·Virginia Almadana PachecoTeodoro Montemayor Rubio
Nov 15, 2013·Chronic Illness·Samantha Louise HarrisonNoelle Robertson
Sep 3, 2011·Physiotherapy Canada. Physiothérapie Canada·Kylie Johnston, Karen Grimmer-Somers
Jul 18, 2017·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·David A KaminskyNicola A Hanania
Feb 24, 2015·The Cochrane Database of Systematic Reviews·Bernard McCarthyYves Lacasse
May 6, 2019·American Journal of Respiratory and Critical Care Medicine·Linda NiciRichard L ZuWallack
Apr 2, 2011·Current Opinion in Supportive and Palliative Care·Amy P AbernethyChristopher Cox
Jun 24, 2017·Journal of Cardiopulmonary Rehabilitation and Prevention·Kate CullenJulie Broderick
Dec 29, 2018·Annals of the American Thoracic Society·Surya P Bhatt
Nov 2, 2016·The Cochrane Database of Systematic Reviews·Joseph Em van AgterenBrian J Smith
Feb 16, 2021·ERJ Open Research·Philip W StoneSally J Singh
Mar 2, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Mai TsutsuiDon D Sin
Mar 2, 2021·Rehabilitación·D C Serpa-AnayaN L Hernandez
Jan 7, 2021·Lung India : Official Organ of Indian Chest Society·Anulucia AugustineRahul Magazine
Jul 1, 2021·Disability and Rehabilitation·Stephanie ChauvinMarla K Beauchamp
Mar 18, 2019·Respiration; International Review of Thoracic Diseases·Berthold H JanyWinfried Randerath

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.